- Record: found
- Abstract: not found
- Article: not found
A Phase III, multicenter, randomized, double-blind, placebo controlled, comparative trial of AMD3100 (plerixafor)+G-CSF vs placebo+G-CSF in non-Hodgkin’s lymphoma (NHL) patients for autologous hematopoietic stem cell (aHSC) transplantation [49th ASH Annual Meeting Abstract]
2007
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.